The FDA has issued an alert to health care professionals and patients to not use drug products intended to be sterile that were produced in an inadequately designed processing room.

The National Committee for Quality Assurance has certified ELEVATE! Quality Insights software by Advantmed, LLC, an integrated risk-adjustment optimization and quality improvement company, for 2019 HEDIS hybrid measures.

Less than 40% of individuals with familial hypercholesterolemia (FH) receive appropriate high-intensity statin therapy, according to new research.

Low and high concentrations of high-density lipoprotein cholesterol (HDL-C) may be associated with an increased risk of infectious disease in the general population, according to new findings.

High variability in weight, blood pressure (BP), cholesterol, and blood sugar levels in otherwise healthy individuals could predict mortality and cardiovascular events, according to the results of a recent study.

“Our comprehensive state-specific estimates provide essential information needed by state policymakers to monitor the economic burden of the disease and to better plan and evaluate interventions for preventing type 2 diabetes and managing diabetes in their states,” researchers wrote.

Certain characteristics may predict a patient’s level of migraine-specific health care costs, according to a study in the Journal of Managed Care & Specialty Pharmacy.

For patients with moderate to severe plaque psoriasis with an inadequate response to methotrexate and phototherapy, researchers have investigated whether or not IL-17 inhibitors are an effective treatment strategy. 

A prescription antibiotic used to treat acne is being recalled by the FDA. 

A Class II recall is active for a prescription antipsychotic medication used to treat patients with schizophrenia, bipolar disorder, and depression.